Paid Clinical Trials Allentown

Discover 2,151 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,151

ADI-PEG 20Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects with Leiomyosarcoma (ARGSARC)

Recruiting

PHASE3

Sponsor:

Polaris Group

Location:

Philadelphia PA, New York NY, Pittsburg PA, Boston MAshow 21 more

Code:

NCT05712694

Conditions

Soft Tissue Sarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

ADI PEG20

Placebo

Peposertib & AvelumabTesting the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Recruiting

PHASE1

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

New Brunswick NJ, New York NY, Greenwich CT, Stamford CTshow 31 more

Code:

NCT04068194

Conditions

Locally Advanced Malignant Solid Neoplasm

Locally Advanced Unresectable Cholangiocarcinoma

Locally Advanced Unresectable Gallbladder Carcinoma

Locally Advanced Unresectable Malignant Solid Neoplasm

Metastatic Cholangiocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Avelumab

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Hypofractionated Radiation Therapy

BI 1839100A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Recruiting

PHASE2

Sponsor:

Boehringer Ingelheim

Location:

Philadelphia PA, New York NY, Mount Kisco NY, DuBois PAshow 21 more

Code:

NCT06360094

Conditions

Idiopathic Pulmonary Fibrosis

Progressive Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BI 1839100

Placebo

TVT EXACT®Post-Market Clinical Follow-Up onTVT EXACT® Continence System

Recruiting

Sponsor:

Ethicon, Inc.

Location:

North Wales PA, Pittsburgh PA, Durham NC

Code:

NCT04829994

Conditions

Stress Urinary Incontinence

Eligibility Criteria

Sex: Female

Age: 21+

Healthy Volunteers: Not accepted

Interventions

Intervention

Abdominal BindersThe Use of Abdominal Binders in Patients Undergoing Cesarean Sections

Recruiting

PHASE3

Sponsor:

St. Luke's Hospital, Pennsylvania

Location:

Bethlehem PA

Code:

NCT02129894

Conditions

Cesarean Section Post Operative Management

Eligibility Criteria

Sex: Female

Age: 18 - 50

Healthy Volunteers: Not accepted

Interventions

abdominal Binder

Optimizing TreatmentOptimizing Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome (OPTimize NOW): A Symptom-Based Dosing Approach

Recruiting

PHASE3

Sponsor:

HELP for NOWS Consortium

Location:

Philadelphia PA, Wilmington DE, Atlantic City NJ, Rochester NYshow 16 more

Code:

NCT05980260

Conditions

Neonatal Opiate Withdrawal Syndrome

Eligibility Criteria

Sex: All

Age: 1 - 48

Healthy Volunteers: Not accepted

Interventions

Symptom-based Dosing Approach

Scheduled Opioid Taper Approach

BleximenibA Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia

Recruiting

PHASE1

PHASE2

Sponsor:

Janssen Research & Development, LLC

Location:

Philadelphia PA, New York NY, Bronx NY, Providence RIshow 21 more

Code:

NCT04811560

Conditions

Acute Leukemias

Acute Myeloid Leukemia

Acute Lymphoblastic Leukemia

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Bleximenib

Observational StudyMucopolysaccharidosis I (MPS I) Registry

Recruiting

Sponsor:

Genzyme, a Sanofi Company

Location:

Philadelphia PA, Morristown NJ, New Brunswick NJ, Paterson NJshow 62 more

Code:

NCT00144794

Conditions

Mucopolysaccharidosis I (MPS I)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Digital HealthReducing Challenging Behaviors in Children With Autism Through Digital Health

Recruiting

Sponsor:

University of Pennsylvania

Location:

Philadelphia PA

Code:

NCT05277194

Conditions

Autism Spectrum Disorder

Eligibility Criteria

Sex: All

Age: 3 - 13

Healthy Volunteers: Not accepted

Interventions

KeepCalm app

ItepekimabA Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

Recruiting

PHASE2

Sponsor:

Sanofi

Location:

Philadelphia PA, New York NY, New Haven CT, Farmington CTshow 28 more

Code:

NCT06280391

Conditions

Bronchiectasis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Itepekimab (SAR440340)

Placebo